FDA Accepts Application for Langlara (Insulin Glargine-Aldy) by Sunshine Lake Pharma
The FDA has accepted the Biologics License Application for Langlara, an insulin glargine product from Sunshine Lake Pharma.
Therapeutic Area
Therapeutic area intelligence for Insulin with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
The FDA has accepted the Biologics License Application for Garzulys, an insulin aspart formulation.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.